FORA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
FORA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Forian's average Accounts Receivable for the three months ended in Sep. 2024 was $3.61 Mil. Forian's Revenue for the three months ended in Sep. 2024 was $4.69 Mil. Hence, Forian's Days Sales Outstanding for the three months ended in Sep. 2024 was 70.27.
The historical rank and industry rank for Forian's Days Sales Outstanding or its related term are showing as below:
During the past 5 years, Forian's highest Days Sales Outstanding was 62.88. The lowest was 15.40. And the median was 30.18.
Forian's Days Sales Outstanding increased from Sep. 2023 (57.66) to Sep. 2024 (70.27).
The historical data trend for Forian's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Forian Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Days Sales Outstanding | - | 15.40 | 21.31 | 41.76 | 39.05 |
Forian Quarterly Data | |||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Days Sales Outstanding | Get a 7-Day Free Trial | 57.66 | 46.67 | 64.00 | 75.82 | 70.27 |
For the Health Information Services subindustry, Forian's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Forian's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Forian's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Forian's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as
Days Sales Outstanding (A: Dec. 2023 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2022 ) | + | Accounts Receivable (A: Dec. 2023 )) | / | count ) | / | Revenue (A: Dec. 2023 ) | * | Days in Period |
= | ( (1.809 | + | 2.573) | / | 2 ) | / | 20.481 | * | 365 |
= | 2.191 | / | 20.481 | * | 365 | ||||
= | 39.05 |
Forian's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:
Days Sales Outstanding (Q: Sep. 2024 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Jun. 2024 ) | + | Accounts Receivable (A: Sep. 2024 )) | / | count ) | / | Revenue (A: Sep. 2024 ) | * | Days in Period |
= | ( (3.67 | + | 3.547) | / | 2 ) | / | 4.686 | * | 365 / 4 |
= | 3.6085 | / | 4.686 | * | 365 / 4 | ||||
= | 70.27 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Forian (NAS:FORA) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Forian's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Martin J Wygod | director | P.O. BOX 676306, RANCHO SANTA FE CA 92067 |
Trotman Stanley S Jr | director | |
Max C Wygod | director, officer: Executive Chairman | 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940 |
Max Wygod Family Dynasty Trust | 10 percent owner | 41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940 |
Michael Vesey | officer: Chief Financial Officer | 4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080 |
Jennifer Hajj | director | 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940 |
Kristiina Md Vuori | director | C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011 |
Scott Matthew Ogur | director | C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231 |
Farren Clifford A Jr | officer: Chief Financial Officer | C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326 |
Adler Mark J Md | director | |
Ian Banwell | director | P.O. BOX 34004, CHARLOTTE NC 28234 |
Shahir Kassam-adams | director | 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940 |
Adam H Dublin | director, officer: Chief Strategy Officer | 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940 |
Daniel J Barton | director, officer: Chief Executive Officer | 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940 |
Alyssa F Varadhan | director | 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940 |
From GuruFocus
By GuruFocus Research • 03-29-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 05-15-2024
By GuruFocus Research • 03-28-2024
By Marketwired • 11-08-2024
By Marketwired • 11-01-2024
By GuruFocus Research • 05-15-2024
By Marketwired • 08-02-2024
By GuruFocus News • 11-13-2024
By GuruFocus Research • 02-07-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.